ARAMIS BIOSCIENCES
Aramis Biosciences provides disease-modifying therapy for ocular surface disease and is an immuno-ophthalmology biopharmaceutical company. For inquiries, email, telephone numbers, and physical addresses are available on their website.
ARAMIS BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.aramisbio.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
U.S. Server Location
Similar Organizations
Asana BioSciences
Asana BioSciences is a clinical-stage biopharmaceutical company.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
ViCardia
ViCardia is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Safar Partners
Safar Partners investment in Seed Round - Aramis Biosciences
Official Site Inspections
http://www.aramisbio.com Semrush global rank: 8.13 M Semrush visits lastest month: 643
Unable to get host informations!!!
More informations about "Aramis Biosciences"
About - Aramis Biosciences
Aramis Biosciences was founded in 2018 following more than a decade of research at The Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, where the role of a …See details»
Contact - Aramis Biosciences
Organization Message Thank you for your message. Submit Aramis Biosciences 266 Main Street, Building 2, Suite 11 Medfield, MA 02052 Additional Inquires can be sent to the following: …See details»
Aramis Biosciences - Crunchbase Company Profile & Funding
Aramis Biosciences provides disease-modifying therapy for ocular surface disease and is an immuno-ophthalmology biopharmaceutical company. For inquiries, email, telephone numbers, …See details»
Aramis Biosciences - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Aramis Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Aramis Biosciences - LinkedIn
Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface disease.See details»
Aramis Biosciences - Overview, News & Similar companies
Jan 10, 2022 Who is Aramis Biosciences. Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease …See details»
Aramis Biosciences - VentureRadar
"Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface disease.See details»
Aramis Biotechnologies | Plant-based vaccine technology
Notre technologie . En s’appuyant sur la capacité unique des cellules végétales, Aramis Biotechnologies développe une nouvelle génération de plateforme de biofabrication dans les plantes pour répondre aux besoins de santé publique …See details»
Aramis Biosciences Overview | SignalHire Company Profile
Organization Website: aramisbio.com : Aramis Biosciences industries Biotech: Headquarters Location: Boston, MA, US Boston, MA, US : Aramis Biosciences Employees Size 1-10 …See details»
Aramis Biosciences Launches to Address Unmet Needs in Ocular …
Dec 15, 2021 [email protected]. For inquiries on Dompé farmaceutici and EXSCALATE: Guido Romeo – Head Corporate Communications Mob. +39 349 4154010 …See details»
Aramis Biosciences - workinbiotech.com
Aramis Biosciences is concentrated on creating novel disease-modifying treatments for dry eye disease, which is highly undertreated. They are a Massachusetts-based clinical-stage …See details»
Corporate culture - Aramis Biotechnologies
Our Vision and Mission Our vision is to become the world leader in the manufacturing of plant-based vaccines and our mission is to sustainably address the world's human health needs. By …See details»
Biotechnologies Aramis Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biotechnologies Aramis Inc of Québec, QC. Get the latest business insights from Dun & …See details»
Aramis Biotechnologies | Plant-based vaccine technology
Our technology . Drawing on the unique capacity of plant cells, Aramis Biotechnologies is developing a new generation of biomanufacturing platforms in plants to meet current public …See details»
Aramis Biosciences Announces First Patient Dosed in Phase II …
Feb 28, 2022 “We are thrilled with the study team assembled for this clinical trial, from our contract research organization to our clinical investigators, and look forward to topline proof of …See details»
Aramis Biotechnologies and the Biologics Manufacturing Centre …
Feb 14, 2025 Agreement on Formulation and Finish of a Virus-Like Particle Vaccine for Phase 1 and 2 Clinical Trials. Montreal and Quebec City, February 14, 2025 – Aramis Biotechnologies …See details»
Aramis Biosciences Launches to Address Unmet Needs in Ocular …
Dec 16, 2021 (PRESS RELEASE) BOSTON, MA — Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the …See details»
Aramis Biosciences Announces First Patient Dosed in Phase
BOSTON, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced that the first patient …See details»
Pipeline - Aramis Biosciences
Pipeline Aramis Biosciences was founded to revolutionize the standard of care in ocular immunology, beginning with Dry Eye Disease.See details»
Aramis Biotechnologies secures $80M CAD to relaunch Plant …
Dec 9, 2024 A Second Chance for Plant-Based Vaccines. Aramis Biotechnologies was founded in 2023 by former employees of Medicago, a failed biotech firm shuttered by Mitsubishi …See details»